Insider Name | Buy/Sell | Amount | Shares Change | |||
---|---|---|---|---|---|---|
Feb 11, 2022 | Feb 15, 2022 | King Andrew James Chief Scientific Officer | Sell | $12.74 | $31,827 | -22.93% |
Feb 11, 2022 | Feb 15, 2022 | Glicklich Alan Chief Medical Officer | Sell | $12.74 | $30,464 | -23.25% |
Feb 11, 2022 | Feb 15, 2022 | Frohlich Tom COO | Sell | $12.74 | $47,587 | -2.64% |
Feb 10, 2022 | Feb 11, 2022 | King Andrew James Chief Scientific Officer | Sell | $13.31 | $33,275 | -37.91% |
Jan 03, 2022 | Jan 05, 2022 | Versant Venture Capital Vii, L.P. 10% | Sell | $16 | $16M | -19.32% |
Jan 03, 2022 | Jan 05, 2022 | Jerel Davis Dir 10% | Sell | $16 | $16M | -64.43% |
Nov 15, 2021 | Nov 17, 2021 | Akkaraju Srinivas Dir | Buy | $14 | $17M | +20.92% |
Nov 10, 2021 | Nov 13, 2021 | Frohlich Tom COO | Sell | $15.48 | $96,440 | -4.42% |
Nov 09, 2021 | Nov 13, 2021 | King Andrew James Chief Scientific Officer | Sell | $13.53 | $67,660 | -54.98% |
Nov 05, 2021 | Nov 10, 2021 | Frohlich Tom COO | Sell | $14.48 | $488,938 | -19.34% |
Sep 24, 2021 | Sep 25, 2021 | Frohlich Tom COO | Sell | $13 | $260,000 | -13.04% |
Sep 20, 2021 | Sep 22, 2021 | Dobmeier Eric Pres CEO | Buy | $12 | $24,000 | +1.79% |
Aug 27, 2021 | Aug 31, 2021 | Jerel Davis Dir 10% | Sell | $14 | $12M | -56.89% |
Aug 27, 2021 | Aug 31, 2021 | Versant Venture Capital Vii, L.P. 10% | Sell | $14 | $12M | -14.87% |
Aug 18, 2021 | Aug 20, 2021 | Akkaraju Srinivas Dir | Buy | $11.98 | $2M | +5.82% |
Aug 18, 2021 | Aug 19, 2021 | Dobmeier Eric Pres CEO | Buy | $11.82 | $118,163 | +8.49% |
Jun 16, 2021 | Jun 17, 2021 | Glicklich Alan Chief Medical Officer | Sell | $16.35 | $326,968 | -0 |
May 14, 2021 | May 18, 2021 | Dobmeier Eric Pres CEO | Buy | $14.44 | $14,440 | +1.27% |
Dec 08, 2020 | Dec 10, 2020 | Dobmeier Eric Pres CEO | Buy | $13.16 | $52,633 | +6.57% |
Nov 19, 2020 | Nov 24, 2020 | Dobmeier Eric Pres CEO | Buy | $13.63 | $27,266 | +3.65% |
Nov 10, 2020 | Nov 13, 2020 | Dobmeier Eric Pres CEO | Buy | $13.8 | $62,095 | +8.13% |